Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
株式のランク #12697
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
株価
$2.04
時価総額
$122.58M
変化(1日)
4.48%
変化(1年)
-1.05%
FR
取引 Crossject Société Anonyme (ALCJ)

カテゴリー

Crossject Société Anonyme(ALCJ)の株式分割履歴
Crossject Société Anonyme株(シンボル:ALCJ)は合計で2回の株式分割を実施しました。
最新の株式分割はNov 29, 2018に行われました。
Mar 14, 2017より前に購入されたALCJ株は、現在1.046448ALCJ株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2018-11-29 129:125 x1.032 x1.046448
2017-03-14 507:500 x1.014 x1.014
類似企業または競合他社の株式分割